Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

SHA:600613 Revenue

Shanghai Shenqi Pharmaceutical Investment Management had revenue of 437.01M CNY in the quarter ending September 30, 2025, a decrease of -3.51%. This brings the company's revenue in the last twelve months to 1.88B, down -14.14% year-over-year. In the year 2024, Shanghai Shenqi Pharmaceutical Investment Management had annual revenue of 2.05B, down -12.48%.

• Revenue (ttm): 1.88B
• Revenue Growth: -14.14%
• P/S Ratio: 1.70
• Revenue / Employee: 1.49M
• Employees: 1,266
• Market Cap: 3.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.05B	-292.14M	-12.48%
Dec 31, 2023	2.34B	-47.67M	-2.00%
Dec 31, 2022	2.39B	85.58M	3.72%
Dec 31, 2021	2.30B	484.03M	26.61%
Dec 31, 2020	1.82B	-108.59M	-5.63%